Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: Global

Adamant Funds - Adamant Global Generika Fund

+ Add to Watchlist

ADAGGRI:SW

1,485.73 CHF 2.81 0.19%

As of 11:34:00 ET on 01/27/2015.

Snapshot for Adamant Funds - Adamant Global Generika Fund (ADAGGRI)

Year To Date: -4.68% 3-Month: -1.49% 3-Year: +17.19% 52-Week Range: 1,220.28 - 1,642.29
1-Month: -2.71% 1-Year: +19.89% 5-Year: - Beta vs SMI: 0.92

Mutual Fund Chart for ADAGGRI

No chart data available.
  • ADAGGRI:SW 1,485.73
  • 1M
  • 1Y
Interactive ADAGGRI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ADAGGRI

Adamant Global Generika Fund is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the generic sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.

Inception Date: 07-16-2010 Telephone: +41 800 850 050
Managers: OLIVER KUBLI
Web Site: www.zkb.ch/fonds

Fundamentals for ADAGGRI

NAV (on 2015-01-27) 1,485.73
Assets (M) (on 2015-01-27) 177.57
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment -

Dividends for ADAGGRI

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2012-12-05) 4.00
Dividend Yield (ttm) -

Fees & Expenses for ADAGGRI

Front Load 1.20
Back Load 1.00
Current Mgmt Fee 1.20
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.22

Top Fund Holdings for ADAGGRI

Filing Date: 08/29/2014
Name Position Value % of Total
Medy-Tox Inc 40,000 7,296,240 4.221%
Teva Pharmaceutical Industries 150,000 7,215,066 4.174%
Dr Reddy's Laboratories Ltd 150,000 6,732,871 3.895%
Aspen Pharmacare Holdings Ltd 250,000 6,580,110 3.807%
Sinopharm Group Co Ltd 2,000,000 6,393,105 3.699%
Sino Biopharmaceutical Ltd 7,500,000 6,328,111 3.661%
Lonza Group AG 60,000 6,306,000 3.648%
Actavis plc 30,000 6,236,389 3.608%
Mallinckrodt PLC 80,000 5,970,609 3.454%
Celltrion Inc 166,373 5,959,297 3.448%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil